Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development.Pertussis Across the Globe: Recent Epidemiologic Trends From 2000-2013.Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.Erratum for Carbonetti et al., "Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development".Immunization with the recombinant Cholera toxin B fused to Fimbria 2 protein protects against Bordetella pertussis infection.Cyclic-di-GMP signalling regulates motility and biofilm formation in Bordetella bronchiseptica.In vitro and in vivo characterization of a Bordetella bronchiseptica mutant strain with a deep rough lipopolysaccharide structure.Resurgence of pertussis calls for re-evaluation of pertussis animal models.Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.Laboratory adaptation of Bordetella pertussis is associated with the loss of type three secretion system functionality.Characterization of the key antigenic components of pertussis vaccine based on outer membrane vesicles.Intranasal administration of TLR agonists induces a discriminated local innate response along murine respiratory tract.Acid tolerance response of Bordetella bronchiseptica in avirulent phase.Characterization of the immune response induced by pertussis OMVs-based vaccine.Strategies and new developments to control pertussis, an actual health problemRelaxed sugar donor selectivity of a Sinorhizobium meliloti ortholog of the Rhizobium leguminosarum mannosyl transferase LpcC. Role of the lipopolysaccharide core in symbiosis of Rhizobiaceae with plantsDevelopment of improved pertussis vaccine.Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012Pertussis epidemiology in Argentina: trends over 2004-2007.Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.Assessment of pertussis vaccination strategies using a mathematical model of disease transmission.Pertussis in Latin America: epidemiology and control strategies.Potential Impact of Changes in the Schedule for Primary DTP Immunization as Control Strategy for Pertussis.Genetic characterization of a Sinorhizobium meliloti chromosomal region in lipopolysaccharide biosynthesis.Development and assessment of a new cage-like particle adjuvant.Mathematical modeling of delayed pertussis vaccination in infants.Prevalence of Pertussis Antibodies in Maternal Blood, Cord Serum, and Infants From Mothers With and Those Without Tdap Booster Vaccination During Pregnancy in Argentina.Outer membrane vesicles: an attractive candidate for pertussis vaccines.The stimulated innate resistance event in Bordetella pertussis infection is dependent on reactive oxygen species production.Pertussis Maternal Immunization: Narrowing the Knowledge Gaps on the Duration of Transferred Protective Immunity and on Vaccination Frequency.Epidemiological situation of pertussis and strategies to control it: Argentina, 2002-2011.Modelling the effect of changes in vaccine effectiveness and transmission contact rates on pertussis epidemiology.Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America.[Optimization of processing and storage of clinical samples to be used for the molecular diagnosis of pertussis].Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production.Construction of a Sinorhizobium meliloti strain carrying a stable and non-transmissible chromosomal single copy of the green fluorescent protein GFP-P64L/S65T.Effect of hydromechanical stress on cellular antigens of Bordetella pertussis.The global pertussis initiative: Meeting report from the Regional Latin America Meeting, Costa Rica, 5-6 December, 2008.Mucosal innate response stimulation induced by lipopolysaccharide protects against Bordetella pertussis colonization.Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
P50
Q30245164-DC8497C5-C90F-4BA7-99BA-27F078430109Q30488060-0D157571-7360-4B28-A268-63F4AD8F2332Q30833407-25B8293D-23AF-4D04-B016-77000EC49C94Q33654556-80D82B95-6FD6-4A66-A73B-00D0E910C602Q33738499-B806D9D0-9B98-4F12-A558-130331D7EE2CQ33860272-347082AE-AC0C-4DA0-B225-58CEE1C8C404Q34120683-243BC7B2-0A3F-4809-83FA-2B89D998DE2BQ34311615-876AB464-E9AC-42AC-877C-FCF30E33AB6EQ35084516-3E11DE7D-20B4-4F8C-ACAF-88B7FB2F204EQ35191908-474ECF4F-DF26-4211-98B2-0128BA63D0AAQ35266726-0B3F0970-C69D-4B5C-9A23-1179019621F3Q35552383-5BD0575E-E46E-42A3-A8C1-CC5FA21CEED2Q35861823-29312B67-1B0B-4100-8931-4FD46A8827DAQ36010403-19D77EFB-66CF-49F7-AC1A-C1F692EB8740Q36226470-6162191B-9D8E-4C6B-967F-149F2C62B2A0Q36907073-F459BD3E-C469-48E8-A5F5-D6EC7EC569EEQ36978320-B3523FA2-993A-4E89-9EB9-9FE3874A8292Q37182380-0977C946-D3B8-4DCB-B9E3-C363BFB89336Q37570708-5B3B8ACB-B871-4B22-A6C9-C119CA1F18D6Q37714873-F154C4C3-32AF-468C-A713-FFF9B85B2180Q38149001-13A5B4A7-8743-48A1-A871-BE6330E8C312Q38241405-272F436A-E317-4D5B-8343-CDBFA2E04F54Q38599797-3E2EDE20-D77C-452E-B083-144C571D86A8Q39502466-24E93783-EAEA-49D4-B9E9-CB5C3810C6EAQ40152711-0E0F6C84-B56C-440E-B079-4B408BF20BB2Q40297628-BC79F161-EF54-42E8-8AF4-D1B72304B30BQ40389275-C98CC88E-4638-4C2D-9F63-C8FEF429660AQ40410058-4D12BD81-3C0C-495D-9B85-FEBE4D239444Q41432217-5B8952A8-7829-43AF-9DF9-39D0A917C070Q41440604-84EF0327-3961-47AE-8B2B-023080B165ABQ41752361-05ED6F91-A282-4083-9B22-091321041045Q42210541-C4722564-7930-42A3-8C72-B01B827BE409Q42642555-04E8D743-F095-4661-8DC2-BFD8315952A0Q43000609-AB0F2134-06BC-48FC-9137-2D429DFEB43DQ43587300-5A85AEAC-8F14-43B2-B85B-E64E63530548Q44155050-D9DF2775-2642-414E-812C-B2E4F80F538EQ44568131-F9941013-1806-4775-93A9-C8F9C2C0A09FQ45142786-91FD5537-19BF-447B-8254-3A360E05AF0CQ46748071-A9B32085-5387-46B0-83A7-2B3B61AC8769Q47698380-CF90DB4B-F814-401A-A884-751F258BB4D0
P50
description
Argentijns onderzoekster
@nl
Argentine biochemist
@en
Biochimie argentine
@fr
Bioquímica argentina
@es
bithchemiceoir Airgintíneach
@ga
name
Daniela Flavia Hozbor
@ast
Daniela Flavia Hozbor
@en
Daniela Flavia Hozbor
@es
Daniela Flavia Hozbor
@fr
Daniela Flavia Hozbor
@ga
Daniela Flavia Hozbor
@nl
Daniela Flavia Hozbor
@sl
Daniela Flavia Hozbor
@sq
type
label
Daniela Flavia Hozbor
@ast
Daniela Flavia Hozbor
@en
Daniela Flavia Hozbor
@es
Daniela Flavia Hozbor
@fr
Daniela Flavia Hozbor
@ga
Daniela Flavia Hozbor
@nl
Daniela Flavia Hozbor
@sl
Daniela Flavia Hozbor
@sq
altLabel
D Hozbor
@en
D Hozbor
@es
D Hozbor
@fr
DF Hozbor
@en
DF Hozbor
@es
DF Hozbor
@fr
Daniela F Hozbor
@en
Daniela F Hozbor
@es
Daniela F Hozbor
@fr
prefLabel
Daniela Flavia Hozbor
@ast
Daniela Flavia Hozbor
@en
Daniela Flavia Hozbor
@es
Daniela Flavia Hozbor
@fr
Daniela Flavia Hozbor
@ga
Daniela Flavia Hozbor
@nl
Daniela Flavia Hozbor
@sl
Daniela Flavia Hozbor
@sq
P103
P1412
P1559
Daniela Flavia Hozbor
@es
P1960
Ibu-9yMAAAAJ
P2038
Daniela_Hozbor
P21
P27
P2798
P31
P373
Daniela Hozbor
P3829
P496
0000-0001-6379-0482